These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 31451647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells.
    Nakajima K, Jain S, Ruiz de Azua I, McMillin SM, Rossi M, Wess J.
    Mol Endocrinol; 2013 Aug; 27(8):1208-16. PubMed ID: 23820900
    [Abstract] [Full Text] [Related]

  • 3. Beneficial metabolic effects caused by persistent activation of beta-cell M3 muscarinic acetylcholine receptors in transgenic mice.
    Gautam D, Ruiz de Azua I, Li JH, Guettier JM, Heard T, Cui Y, Lu H, Jou W, Gavrilova O, Zawalich WS, Wess J.
    Endocrinology; 2010 Nov; 151(11):5185-94. PubMed ID: 20843999
    [Abstract] [Full Text] [Related]

  • 4. Beta-cell M3 muscarinic acetylcholine receptors as potential targets for novel antidiabetic drugs.
    Zhu L, Rossi M, Doliba NM, Wess J.
    Int Immunopharmacol; 2020 Apr; 81():106267. PubMed ID: 32044662
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice.
    Duttaroy A, Zimliki CL, Gautam D, Cui Y, Mears D, Wess J.
    Diabetes; 2004 Jul; 53(7):1714-20. PubMed ID: 15220195
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications.
    Ruiz de Azua I, Gautam D, Guettier JM, Wess J.
    Trends Endocrinol Metab; 2011 Feb; 22(2):74-80. PubMed ID: 21106385
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M, Shi YC, Chan JY, Laybutt DR, Chae H, Abou-Samra M, Pappas EG, Thomas HE, Gilon P, Jonas JC.
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor.
    Doliba NM, Liu Q, Li C, Chen P, Liu C, Naji A, Matschinsky FM.
    Mol Metab; 2017 Oct; 6(10):1240-1253. PubMed ID: 29031723
    [Abstract] [Full Text] [Related]

  • 16. Insulin oversecretion in MSG-obese rats is related to alterations in cholinergic muscarinic receptor subtypes in pancreatic islets.
    Miranda RA, Agostinho AR, Trevenzoli IH, Barella LF, Franco CC, Trombini AB, Malta A, Gravena C, Torrezan R, Mathias PC, de Oliveira JC.
    Cell Physiol Biochem; 2014 Oct; 33(4):1075-86. PubMed ID: 24732778
    [Abstract] [Full Text] [Related]

  • 17. Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptors.
    Ruiz de Azua I, Gautam D, Jain S, Guettier JM, Wess J.
    Life Sci; 2012 Nov 27; 91(21-22):986-91. PubMed ID: 22525375
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impaired muscarinic type 3 (M3) receptor/PKC and PKA pathways in islets from MSG-obese rats.
    Ribeiro RA, Balbo SL, Roma LP, Camargo RL, Barella LF, Vanzela EC, de Freitas Mathias PC, Carneiro EM, Boschero AC, Bonfleur ML.
    Mol Biol Rep; 2013 Jul 27; 40(7):4521-8. PubMed ID: 23652999
    [Abstract] [Full Text] [Related]

  • 20. SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells.
    Hu L, He F, Huang M, Zhao Q, Cheng L, Said N, Zhou Z, Liu F, Dai YS.
    Sci Rep; 2020 Oct 16; 10(1):17581. PubMed ID: 33067534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.